Abbott Laboratories
$117.19
-0.06 (-0.06%) Today
About
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
CEO
Miles D. White
Employees
107000
Headquarters
100 Abbott Park Road Abbott Park, IL, 60064-6400
Founded
1888
Market Cap
Abbott Laboratories News
3 cases that changed the patent disclosure landscape of proteins
Dec 15, 2020
In the late 1990s and early to mid 2000s, the consensus in case law and within United States Patent and Trademark Office (USPTO) guidelines was that determination of an antigen was sufficient to allow a patentee to claim the genus of antibodies that bound the antigen. This rationale was based on the idea that once…
Qiagen readies portable digital COVID-19 antigen test
Nov 12, 2020
Qiagen (NYSE: QGEN) and its partner Ellume are gearing up for the launch of the QIAreach SARS-CoV-2 antigen test, which can reportedly process samples in 2–15 minutes. Qiagen notes that the test can process up to 30 swab samples per hour while supporting parallel processing of antibody tests. The companies have submitted the test for […]
Abbott alleges former employee took trade secrets related to COVID-19 products
Nov 03, 2020
Abbott Laboratories has obtained a temporary restraining order against a former marketing executive. The company alleges the former employee stole trade secrets, including details of upcoming COVID-19 products, before accepting a role at a competitor. Virginia Kendall, a U.S. District Judge for the Northern District of Illinois, decided to grant the two-week restraining order against…
Abbott accuses former employee of masquerading as COVID-19 test salesman
Oct 21, 2020
Abbott Laboratories has sued a former employee for trademark infringement and theft of trade secrets, accusing him of selling other manufacturers’ COVID-19 tests on behalf of Abbott. Attorneys for Abbott filed the complaint on Tuesday, seeking a preliminary injunction against Justin Brown as well as monetary damages. Abbott said it fired Brown from his sales […]
COVID-19 diagnostics sales boost Abbott’s Q2 results
Jul 16, 2020
Abbott (NYSE:ABT) beat the consensus forecast on Wall Street today — with sales of molecular diagnostics including COVID-19 tests more than tripling. The Abbott Park, Ill.-based healthcare giant reported profits of $537 million or 57¢ per share, on sales of $7.33 billion for the three months ended June 30, 2020, for a bottom-line plunge of –47% […]
